V029-4074 Screening compound: 2-{5,6-dichloro-2-[(2-fluorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]propanamide

V029-4074 Screening compound: 2-{5,6-dichloro-2-[(2-fluorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]propanamide
V029-4074 Screening compound: 2-{5,6-dichloro-2-[(2-fluorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-4074
2-{5,6-dichloro-2-[(2-fluorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-4074

Molecular Formula

C23H25Cl2FN4O2 (C23 H25 Cl2 FN4 O2)

Compound Name

2-{5,6-dichloro-2-[(2-fluorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]propanamide

IUPAC name

2-{56-dichloro-2-[(2-fluorophenyl)methyl]-1H-13-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]propanamide

SMILES

CC(C(NCCN1CCOCC1)=O)n(c(Cc(cccc1)c1F)nc1c2)c1cc(Cl)c2Cl

InChI

InChI=1S/C23H25Cl2FN4O2/c1-15(23(31)27-6-7-29-8-10-32-11-9-29)30-21-14-18(25)17(24)13-20(21)28-22(30)12-16-4-2-3-5-19(16)26/h2-5,13-15H,6-12H2,1H3,(H,27,31)/t15-/m0/s1

InChI Key

BSEDHVGVICEUQF-HNNXBMFYSA-N

MDL Number (MFCD)

MFCD27633097

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

479.38

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.015

Distribution Coefficient, logD

3.958

Water Solubility, LogSw

-4.33

Polar Surface Area

47.985

Acid Dissociation Constant (pKa)

13.25

Base Dissociation Constant (pKb)

6.55

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

39.10

V029-4074 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V029-4074 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-4074?
Check Price and Availability of V029-4074, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-4074 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-4074
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-4074
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-4074 available by request